Your session is about to expire
← Back to Search
3GT Journaling for Psychological Resilience
N/A
Waitlist Available
Led By Lori M Miller, MAOM, RN
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 weeks
Awards & highlights
Study Summary
This trial is studying how well the Three Good Things (3GT) journaling activity works to improve symptoms of stress, depression, resilience, and happiness.
Eligible Conditions
- Positive Thinking
- Positive Psychology
- Psychological Resilience
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 6 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Perceived Stress
Secondary outcome measures
Subjective Depression
Subjective Happiness
Subjective Resilience
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: 3GT journaling groupExperimental Treatment1 Intervention
Subjects will participate in the Three Good Things (3GT) Positive Psychology journaling activity daily for six weeks.
Group II: Non-journaling groupActive Control1 Intervention
Subjects will not participate in the evening journal activity.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,206 Previous Clinical Trials
3,767,058 Total Patients Enrolled
Lori M Miller, MAOM, RNPrincipal InvestigatorMayo Clinic
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are currently experiencing severe mental health issues such as active suicidal thoughts or drug addiction, except for nicotine addiction. If you have a history of drug addiction, you must have been in recovery for at least one year.You have certain mental health conditions that are currently actively affecting you, such as obsessive-compulsive disorder, panic disorder with agoraphobia or other phobic disorder, severe personality disorders or post-traumatic stress disorder.
Research Study Groups:
This trial has the following groups:- Group 1: 3GT journaling group
- Group 2: Non-journaling group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there remaining vacancies for participants in this experiment?
"In concurrence with the clinicaltrials.gov website, this trial is actively recruiting test subjects. The original posting date was September 30th 2021 and it has recently been updated on February 22nd 2022."
Answered by AI
What is the aggregate headcount of those enrolled in this trial?
"Affirmative. Clinicaltrials.gov data supports that this clinical research, first posted on September 30th 2021, is actively looking for participants. 40 patients are required across one site of the study."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger